Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-001583

President & CEO sold 30,000 shares at $136.90 ($4,107,000)

From the SEC's structured data for this filing

Trades in this filing

KAKKIS EMIL D · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-01-04 Sale : show line 1 in the form −30,000 $136.90 $4,107,000 2,329,741 I
Open-market sales · 30,000 sh · avg $136.90 · $4,107,000
Loading xslF345X03/doc4.xml…